D.E. Shaw & Co’s Aegerion Pharmaceuticals, Inc. AEGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-31,116
| Closed | -$423K | – | 2866 |
|
|
2015
Q3 | $423K | Sell |
31,116
-54,365
| -64% | -$739K | ﹤0.01% | 2110 |
|
|
2015
Q2 | $1.62M | Sell |
85,481
-9,797
| -10% | -$186K | ﹤0.01% | 1583 |
|
|
2015
Q1 | $2.49M | Buy |
95,278
+75,855
| +391% | +$1.98M | ﹤0.01% | 1257 |
|
|
2014
Q4 | $407K | Sell |
19,423
-253,761
| -93% | -$5.32M | ﹤0.01% | 2089 |
|
|
2014
Q3 | $9.12M | Buy |
273,184
+164,317
| +151% | +$5.48M | 0.01% | 662 |
|
|
2014
Q2 | $3.49M | Buy |
108,867
+36,079
| +50% | +$1.16M | ﹤0.01% | 1040 |
|
|
2014
Q1 | $3.36M | Buy |
72,788
+16,154
| +29% | +$745K | ﹤0.01% | 1030 |
|
|
2013
Q4 | $4.02M | Buy |
56,634
+35,241
| +165% | +$2.5M | 0.01% | 976 |
|
|
2013
Q3 | $1.83M | Sell |
21,393
-49,735
| -70% | -$4.26M | ﹤0.01% | 1294 |
|
|
2013
Q2 | $4.51M | Buy |
+71,128
| New | +$4.51M | 0.01% | 851 |
|